BILL NUMBER: AB 1317	INTRODUCED
	BILL TEXT


INTRODUCED BY   Assembly Member Block

                        FEBRUARY 27, 2009

   An act to add Chapter 1.5 (commencing with Section 125325) to Part
5.5 of Division 106 of the Health and Safety Code, relating to
public health.



	LEGISLATIVE COUNSEL'S DIGEST


   AB 1317, as introduced, Block. Assisted oocyte production:
advertisement: information.
   Existing law requires that an oocyte retrieval summary be provided
to the donor of oocytes for research purposes. Existing law requires
that a health care professional in the course of fertility treatment
provide prescribed information to an embryo donor relating to
donation of remaining embryos for research purposes.
   This bill would require an advertisement seeking oocyte donation
associated with the delivery of fertility treatment that includes
assisted oocyte production, to contain a prescribed notice relating
to the potential health risks associated with human egg donation.
   Vote: majority. Appropriation: no. Fiscal committee: no.
State-mandated local program: no.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

  SECTION 1.  Chapter 1.5 (commencing with Section 125325) is added
to Part 5.5 of Division 106 of the Health and Safety Code, to read:
      CHAPTER 1.5.  OOCYTE RETRIEVAL FOR FERTILITY TREATMENT


   125325.  (a) An advertisement seeking oocyte donation associated
with the delivery of fertility treatment that includes assisted
oocyte production shall include the following notice:


   "There are potential risks associated with human egg donation.
Long-term risks associated with human egg donation have not been
determined. Consultation with your reproductive care specialist prior
to entering into a donor contract is advised."


   (b) As used in this section, "assisted oocyte production" has the
same meaning as set forth in subdivision (a) of Section 125330.